Different kinetics of circulating antibody-secreting cell responses after primary and booster oral immunizations: A tool for assessing immunological memory

Vaccine

Volumn 31, Issue 30, 2013, Pages 3035-3038

  Leach, Susannah ^a   Lundgren, Anna ^a   Svennerholm, Ann Mari ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

ALS; Antibody secreting cells; ELISPOT; Immunological memory; Kinetics; Oral vaccination

Indexed keywords

CHOLERA VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL MEMORY; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; ANTIBODY-PRODUCING CELLS; BACTERIAL VACCINES; CHOLERA VACCINES; ENTEROTOXIGENIC ESCHERICHIA COLI; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; KINETICS; MALE; VACCINATION; YOUNG ADULT;

EID: 84878995831     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.04.066     Document Type: Article

References (20)

1. Wenneras C., Svennerholm A.M., Ahren C., Czerkinsky C. Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine. Infect Immun 1992, 60(7):2605-2611.
2. Qadri F., Ahmed T., Ahmed F., Bradley Sack R., Sack D.A., Svennerholm A.M. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18-36 months of age. Vaccine 2003, 21(19-20):2394-2403.
3. Qadri F., Wenneras C., Ahmed F., Asaduzzaman M., Saha D., Albert M.J., et al. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children. Vaccine 2000, 18(24):2704-2712.
4. Jertborn M., Ahren C., Svennerholm A.M. Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine. Clin Diagn Lab Immunol 2001, 8(2):424-428.
5. Savarino S.J., Brown F.M., Hall E., Bassily S., Youssef F., Wierzba T., et al. Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Egyptian adults. J Infect Dis 1998, 177(3):796-799.
6. Savarino S.J., Hall E.R., Bassily S., Brown F.M., Youssef F., Wierzba T.F., et al. Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group. J Infect Dis 1999, 179(1):107-114.
7. Lundgren A., Leach S., Tobias J., Carlin N., Gustafsson B., Jertborn M., et al. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB subunit. Vaccine 2013, 31(8):1163-1170.
8. Harro C., Sack D., Bourgeois A.L., Walker R., DeNearing B., Feller A., et al. A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phase I trial in healthy adults. Clin Vaccine Immunol 2011, 18(12):2118-2127.
9. McKenzie R., Venkatesan M.M., Wolf M.K., Islam D., Grahek S., Jones A.M., et al. Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidate. Vaccine 2008, 26(26):3291-3296.
10. Kantele A., Makela P.H. Different profiles of the human immune response to primary and secondary immunization with an oral Salmonella typhi Ty21a vaccine. Vaccine 1991, 9(6):423-427.
11. Svennerholm A.M., Jertborn M., Gothefors L., Karim A.M., Sack D.A., Holmgren J. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J Infect Dis 1984, 149(6):884-893.
12. Lewis D.J., Novotny P., Dougan G., Griffin G.E. The early cellular and humoral immune response to primary and booster oral immunization with cholera toxin B subunit. Eur J Immunol 1991, 21(9):2087-2094.
13. Lundgren A., Kaim J., Jertborn M. Parallel analysis of mucosally derived B- and T-cell responses to an oral typhoid vaccine using simplified methods. Vaccine 2009, 27(33):4529-4536.
14. Jertborn M., Ahren C., Holmgren J., Svennerholm A.M. Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine. Vaccine 1998, 16(2-3):255-260.
15. Carpenter C.M., Hall E.R., Randall R., McKenzie R., Cassels F., Diaz N., et al. Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers. Vaccine 2006, 24(18):3709-3718.
16. Kirkpatrick B.D., Bentley M.D., Thern A.M., Larsson C.J., Ventrone C., Sreenivasan M.V., et al. Comparison of the antibodies in lymphocyte supernatant and antibody-secreting cell assays for measuring intestinal mucosal immune response to a novel oral typhoid vaccine (M01ZH09). Clin Diagn Lab Immunol 2005, 12(9):1127-1129.
17. Jertborn M., Svennerholm A.M., Holmgren J. Five-year immunologic memory in Swedish volunteers after oral cholera vaccination. J Infect Dis 1988, 157(2):374-377.
18. Svennerholm A.M., Lundgren A. Recent progress toward an enterotoxigenic Escherichia coli vaccine. Expert Rev Vaccines 2012, 11(4):495-507.
19. Halliley J.L., Kyu S., Kobie J.J., Walsh E.E., Falsey A.R., Randall T.D., et al. Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization. Vaccine 2010, 28(20):3582-3587.
20. Blanchard-Rohner G., Pulickal A.S., Jol-van der Zijde C.M., Snape M.D., Pollard A.J. Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humans. Blood 2009, 114(24):4998-5002.